Cargando…
NF-κB: A Druggable Target in Acute Myeloid Leukemia
SIMPLE SUMMARY: AML is a highly heterogeneous hematological disease and is the second most common form of leukemia. Around 40% of AML patients display elevated nuclear NF-κB activity, providing a compelling rationale for targeting the NF-κB pathway in AML. Here we summarize the main drivers of the N...
Autores principales: | Di Francesco, Barbara, Verzella, Daniela, Capece, Daria, Vecchiotti, Davide, Di Vito Nolfi, Mauro, Flati, Irene, Cornice, Jessica, Di Padova, Monica, Angelucci, Adriano, Alesse, Edoardo, Zazzeroni, Francesca |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9319319/ https://www.ncbi.nlm.nih.gov/pubmed/35884618 http://dx.doi.org/10.3390/cancers14143557 |
Ejemplares similares
-
EV-Mediated Chemoresistance in the Tumor Microenvironment: Is NF-κB a Player?
por: Di Vito Nolfi, Mauro, et al.
Publicado: (2022) -
Elevated NF-κB/SHh/GLI1 Signature Denotes a Worse Prognosis and Represent a Novel Potential Therapeutic Target in Advanced Prostate Cancer
por: Vecchiotti, Davide, et al.
Publicado: (2022) -
The NF-κB Pharmacopeia: Novel Strategies to Subdue an Intractable Target
por: Verzella, Daniela, et al.
Publicado: (2022) -
Ultrasound-Based Method for the Identification of Novel MicroRNA Biomarkers in Prostate Cancer
por: Cornice, Jessica, et al.
Publicado: (2021) -
Molecular Mechanisms Underpinning Immunometabolic Reprogramming: How the Wind Changes during Cancer Progression
por: Flati, Irene, et al.
Publicado: (2023)